Morgan Stanley Prefers GoodRx and Healthcare Tech Over Managed Care for 2026
Morgan Stanley prefers GoodRx and broader healthcare technology names over traditional managed-care stocks for 2026, pointing to superior growth, valuation upside and secular tailwinds.
Yahoo Finance
2 min read
Stocks
Market Analysis
Healthcare